Australia's Bio-Gene Technology rises on U.S. deal to develop insecticides

Bio-Gene Technology

04/04/2022 05:03

** Agricultural technology developer Bio-Gene Technology
 BGT.AX  rises as much as 9.8% to A$0.335, its highest since
March 3
    ** Co says http://bio-gene.com.au/wp-content/uploads/2022/04/220404-Clarke-Deal-ASX-Announcement.pdf
 it signed licence and development agreement with U.S.-based
Clarke Mosquito Control Products
    ** Agreement to develop and commercialise new insecticide
solutions for public health markets in the United States and
Cayman Islands
    ** BGT stock dropped nearly 5% earlier in the day
    ** BGT up 48.8% this year, as of last close

 (Reporting by Sameer Manekar in Bengaluru)
 ((Sameer.Manekar@thomsonreuters.com; Twitter: https://twitter.com/sameer_manekar))